LACTOLOGY FOUNDATION

Drugs in ATC class A03B (belladonna and derivatives, plain) are potent anticholinergics with a narrow therapeutic window, relevant mainly as antispasmodics and emergency antidotes, and require great caution in lactating women due to potential toxicity and suppression of milk production.medpedia.framar+3

ATC class A03B overview

ATC A03 belongs to “Drugs for functional gastrointestinal disorders” within the Alimentary tract and metabolism group.wikipedia+2
A03B specifically covers “Belladonna and derivatives, plain”, subdivided into belladonna alkaloids as tertiary amines (A03BA) and semisynthetic quaternary ammonium compounds (A03BB).atcddd.fhi+2

These agents derive from Atropa belladonna and related tropane alkaloids such as atropine, hyoscyamine and scopolamine, used for antispasmodic and anticholinergic effects on smooth muscle and secretory glands.drugbank+2
In contemporary practice, pure belladonna preparations are rarely first‑line for chronic functional GI symptoms because of toxicity and the availability of safer alternatives.droracle+1

Pharmacology and mechanism of action

Belladonna alkaloids are competitive antagonists at muscarinic acetylcholine receptors (M1–M5) in peripheral organs and the central nervous system.drugbank+1
Tertiary amines (e.g. atropine, hyoscyamine, scopolamine) are lipophilic, cross the blood–brain barrier and exert both central and peripheral anticholinergic effects.droracle+1

Semisynthetic quaternary derivatives (e.g. butylscopolamine/cimetropium and related compounds classified in A03BB) are more polar and designed to act mainly peripherally with reduced CNS penetration, while retaining spasmolytic action on GI smooth muscle.atcddd.fhi+2
The overall pharmacodynamic profile includes inhibition of smooth‑muscle tone and motility, reduction of exocrine secretions, tachycardia, and mydriasis, with dose‑dependent progression from therapeutic effects to anticholinergic toxic syndrome.medpedia.framar+1

Indications and clinical use

Within functional gastrointestinal disorders, A03B derivatives are used:

• As antispasmodics for cramping abdominal pain, irritable bowel syndrome, biliary colic and other spastic states of the GI tract, where the main effect is antispasmodic.atcddd.fhi+2
• As adjuncts in acute care (e.g. atropine for severe bradycardia, organophosphate poisoning), although these emergency indications are pharmacological rather than strictly “functional GI”.medpedia.framar+1

Historically, belladonna preparations have been used for asthma, common colds and intestinal spasm, but these uses are now considered poorly supported and overshadowed by toxicity concerns.e-lactation+1
Current guidelines increasingly favour alternative antispasmodics or prokinetic agents with better safety profiles, reserving potent belladonna alkaloids for specific, well‑defined situations and short‑term use.toxylact+2

Toxicology and adverse effects

Atropa belladonna is highly toxic: leaves, fruits and especially the root contain atropine, hyoscyamine and scopolamine, which can cause serious poisoning even at modest doses.e-lactation+2
Typical manifestations of anticholinergic toxicity include mydriasis with blurred vision and photophobia, dry mouth, tachycardia, flushing, urinary retention, constipation, confusion, hallucinations, agitation, seizures and, in severe cases, coma.e-lactation+2

Infants and children are particularly vulnerable, with multiple case reports of severe intoxication requiring intensive care.balimedicaljournal.ejournals+1
Quaternary derivatives reduce CNS penetration but still share many peripheral anticholinergic risks (tachycardia, urinary retention, constipation), especially in overdose or in susceptible patients.atcddd.fhi+2

Management of acute belladonna poisoning is an emergency: supportive care, airway protection, hydration and benzodiazepines for agitation are essential, with early activated charcoal for GI decontamination and physostigmine reserved for severe, life‑threatening anticholinergic syndrome.balimedicaljournal.ejournals+1
Because “natural” products containing belladonna are widely sold, accidental overdoses or misidentification of toxic plants are a recurrent toxicological problem.droracle+1

Contraindications and drug interactions

Belladonna alkaloids are contraindicated in narrow‑angle glaucoma, paralytic ileus, severe ulcerative colitis, unstable cardiovascular status, obstructive uropathy and myasthenia gravis, where anticholinergic effects can markedly worsen the underlying condition.droracle
They should be avoided in elderly patients due to increased sensitivity to cognitive impairment, delirium and falls, and in children because of heightened risk of severe toxicity.droracle

Concomitant use with other anticholinergic drugs (e.g. tricyclic antidepressants, antihistamines, antipsychotics, antiparkinsonian agents) may induce additive or synergistic toxicity, including urinary retention, ileus and confusion.droracle
Combination OTC preparations that include belladonna in multi‑ingredient products of dubious efficacy are strongly discouraged in modern practice.e-lactation+1

Lactation safety: general considerations

For breastfeeding women, A03B agents must be considered from both maternal safety and infant exposure perspectives, adding the risk of reduced milk production.youtubetoxylact+1
General lactation sources emphasise that most medications are compatible with breastfeeding but highlight potent anticholinergics among those requiring caution or avoidance when safer alternatives exist.toxylactyoutube

Belladonna’s antimuscarinic properties can decrease lactation by inhibiting oxytocin‑mediated milk ejection and potentially reducing prolactin‑driven milk synthesis when used at higher or prolonged doses.toxylact+1
Moreover, any transfer of active alkaloids into milk—although not well quantified—could theoretically provoke anticholinergic effects in the nursing infant, who is highly sensitive to these agents.youtubee-lactation

Lactation data for belladonna alkaloids

For herbal belladonna itself, no published quantitative data on excretion of atropine, hyoscyamine or scopolamine into human breast milk have been identified.e-lactation
Despite this lack of direct measurements, toxicological potency and reports of severe poisoning in infants after exposure to belladonna‑containing products indicate that even small milk concentrations might be clinically relevant.balimedicaljournal.ejournals+1

Lactation experts therefore recommend using the lowest possible dose for the shortest duration if a belladonna preparation is absolutely necessary, while monitoring for decreased milk production and infant signs of anticholinergic toxicity (poor feeding, lethargy, hyperthermia, tachycardia, dilated pupils).toxylact+1
Traditional topical use of belladonna plasters on the breast has led to serious complications, including local tissue injury and even gangrene, and is considered contraindicated in breastfeeding women.e-lactation

Quaternary ammonium derivatives (A03BB) are expected to have lower milk penetration due to poor systemic and CNS absorption, but robust clinical lactation studies are lacking, so risk categorisation remains cautious.atcddd.fhi+1
Overall, lactation safety varies markedly between antispasmodics, belladonna alkaloids and prokinetic agents, and in most scenarios safer alternatives should be preferred.toxylact

Risk assessment and practical recommendations in breastfeeding

From a toxico‑lactological perspective, A03B drugs can be roughly positioned as:

• High‑risk: classic belladonna herbal preparations and high‑dose tertiary alkaloids with central effects (e.g. scopolamine, atropine), especially for repeated use.toxylact+2
• Intermediate‑risk: low‑dose tertiary amines used briefly as GI antispasmodics, where careful monitoring and individual risk–benefit assessment are required.drugbank+1
• Lower (but not negligible) risk: peripherally acting quaternary derivatives, where systemic exposure and milk transfer are probably limited, yet data are insufficient to label them unequivocally safe.atcddd.fhi+2

In breastfeeding women, belladonna and derivatives should generally be avoided for routine treatment of functional gastrointestinal complaints when alternatives like non‑anticholinergic antispasmodics or other classes (e.g. selective antiserotonergic agents) are available.atcddd.fhi+2
If use is unavoidable (e.g. emergency atropine), breastfeeding decisions should follow case‑by‑case evaluation, drawing on specialised resources such as LactMed, e‑Lactancia and national toxico‑lactology databases for the specific drug, dose and infant age.youtubee-lactation+1

Role in modern therapeutic practice

Despite long historical use, the significant safety concerns associated with belladonna alkaloids and the availability of more effective, better‑tolerated therapies make A03B drugs a marginal option in contemporary management of functional GI disorders.atcddd.fhi+1
Their current value lies mainly in selected indications (cardiac emergencies, antidotal therapy, short‑term antispasmodic use) under specialist supervision, with explicit attention to contraindications, drug interactions and the patient’s age and comorbidities.medpedia.framar+1

For lactating women, A03B drugs occupy a cautious or unfavourable risk category, where risk minimisation, careful monitoring and preference for non‑anticholinergic alternatives are central principles.e-lactation+1
Healthcare professionals should document counselling, reference specialised lactation information sources and consider temporary scheduling of doses around feeds or expressed milk strategies when high‑risk use cannot be avoided.youtubetoxylact